Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is ...
Phase 1 clinical study data on NRL-1049 shows dose-proportional increase in exposure and favorable safety profile SAN DIEGO, Nov. 6, 2025 /PRNewswire/ -- Neurelis, Inc., today announced it will ...
BioWorld - Saturday, January 10, 2026 Breaking News: BioWorld Science 2025 Year in Review See today's BioWorld Science Home » Human-only RPGR isoform and Rho/ROCK1 inhibitor as approach for X-linked ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results